Mutation analysis in the BRCA2 gene in primary breast cancers
- PMID: 8640237
- DOI: 10.1038/ng0696-245
Mutation analysis in the BRCA2 gene in primary breast cancers
Abstract
Breast cancer, one of the most common and deleterious of all diseases affecting women, occurs in hereditary and sporadic forms. Hereditary breast cancers are genetically heterogeneous; susceptibility is variously attributable to germline mutations in the BRCA1 (ref. 1), BRCA2 (ref. 2), TP53 (ref. 3) or ataxia telangiectasia (ATM) genes, each of which is considered to be a tumour suppressor. Recently a number of germline mutations in the BRCA2 gene have been identified in families prone to breast cancer. We screened 100 primary breast cancers from Japanese patients for BRCA2 mutations, using PCR-SSCP. We found two germline mutations and one somatic mutation in our patient group. One of the germline mutations was an insertion of an Alu element into exon 22, which resulted in alternative splicing that skipped exon 22. The presence of a 64-bp polyadenylate tract and evidence for an 8-bp target-site duplication of the inserted DNA implied that the retrotransposal insertion of a transcriptionally active Alu element caused this event. Our results indicate that somatic BRCA2 mutations, like somatic mutations in the BRCA1 gene, are very rare in primary breast cancers.
Similar articles
-
Low incidence of BRCA2 mutations in breast carcinoma and other cancers.Nat Genet. 1996 Jun;13(2):241-4. doi: 10.1038/ng0696-241. Nat Genet. 1996. PMID: 8640236
-
BRCA2 mutations in primary breast and ovarian cancers.Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235
-
BRCA2 germline mutations in male breast cancer cases and breast cancer families.Nat Genet. 1996 May;13(1):123-5. doi: 10.1038/ng0596-123. Nat Genet. 1996. PMID: 8673091
-
[Molecular genetics of hereditary breast carcinoma].Zentralbl Chir. 1997;122(2):67-73. Zentralbl Chir. 1997. PMID: 9173760 Review. German.
-
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review.
Cited by
-
Roles for retrotransposon insertions in human disease.Mob DNA. 2016 May 6;7:9. doi: 10.1186/s13100-016-0065-9. eCollection 2016. Mob DNA. 2016. PMID: 27158268 Free PMC article. Review.
-
The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.Clin Epigenetics. 2011 Aug;2(2):97-112. doi: 10.1007/s13148-011-0020-z. Epub 2011 Jan 26. Clin Epigenetics. 2011. PMID: 22704332 Free PMC article.
-
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.J Clin Pathol. 2005 May;58(5):493-9. doi: 10.1136/jcp.2004.020388. J Clin Pathol. 2005. PMID: 15858120 Free PMC article.
-
The contribution of germline rearrangements to the spectrum of BRCA2 mutations.J Med Genet. 2006 Sep;43(9):e49. doi: 10.1136/jmg.2005.040212. J Med Genet. 2006. PMID: 16950820 Free PMC article.
-
The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology.Genome Res. 2017 Nov;27(11):1916-1929. doi: 10.1101/gr.218032.116. Epub 2017 Aug 30. Genome Res. 2017. PMID: 28855259 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
